Company / Current Assets
OptimizeRx Corp Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$64.7M
FY2025
5-year range
$32.9M / $98.6M
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 2 years of decline, reaching $65M.
Based on SEC 10-K filings.
$65M in FY2025 with a 5-year CAGR of +14.5%.
Improved from $54M to $65M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -13.1%
- 5-Year CAGR
- +14.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +14.5%, indicating consistent growth.
- In FY2025, current assets increased 19.9% year-over-year.
- Peak current assets was recorded in FY2022.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.7M | +19.9% |
| FY2024 | $54.0M | -0.7% |
| FY2023 | $54.3M | -44.9% |
| FY2022 | $98.6M | +200.0% |
| FY2021 | $32.9M | +0.0% |
| FY2020 | $32.9M | +21.1% |
| FY2019 | $27.1M | +70.0% |
| FY2018 | $16.0M | +81.2% |
| FY2017 | $8.8M | -13.4% |
| FY2016 | $10.2M | -8.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026